LOTTE Biologics dannounce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies, reinforcing a growing strategic partnership. Building on the antibody development/manufacturing agreement signed in June last year, this continu…
Singapore Post Limited and Fullerton Healthcare Group Private Limited have announced the signing of a Memorandum of Understanding dto explore the co-development of a robust, integrated healthcare delivery ecosystem. This collaboration seeks to explore possibilities to leverage SingPost's nationwide and community infr…
Biogen has significantly expanded its immunology and rare disease portfolio through the acquisition of Apellis Pharmaceuticals, a move that includes a total transaction value of approximately $5.6 billion. The agreement marks a major strategic shift for Biogen as it integrates Apellis’ advanced complement-immunotherap…
Labcorp , a global leader of innovative and comprehensive laboratory services, announced an expanded collaboration with Epic, the nation's leading electronic health record (EHR) supporting hospitals and health systems. Through the collaboration, Labcorp's full test menu will be available through Aura, Epic's unified p…
Suzhou Ribo Life Science Co., Ltd. announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine. Both parties will leverage their respective core strengths in siRNA drug development and AI-powered drug discovery to conduct in-depth collaboration in target discovery, drug molec…
Hengrui Pharma and Bristol Myers Squibb announced the companies have entered into global strategic collaboration and license agreements to advance a portfolio of 13 early stage programs in oncology, hematology and immunology, with the goal of accelerating discovery and development of innovative medicines for the benef…
GI Partners, a leading private investment firm, announced it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses from Charles River Laboratories International, Inc., forming Rose BioSolutions ("Rose Bio"), a leading provider of advanced manufact…
Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization (CDMO), and RoosterBio, Inc., a leading supplier of human mesenchymal stem cells (MSCs), engineered bioprocess media, and bioprocess development services, announced a strategic partnership integ…
Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), announced the completion of the acquisition of Tjoapack, a leading global contract packaging organization with facilities in the United States and The Netherlands. The combined organization now employs over 1,400 skil…
Lunai Bioworks, has completed a $20 million preferred equity issuance to acquire intellectual property assets from two counterparties, strengthening its central nervous system (CNS) platform with new neurotherapeutic compounds and delivery technologies. The acquisition is designed to address a key challenge in neurolo…
Page 11 of 39